주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
345 )
기사목록 보기 형태
제목형
요약형
포토형
‘Multinational drugmakers hypocritical in cancer, orphan drug biz’
Nam Doo-hyun
2018.05.23 14:51
Obesity treatment Saxenda supplied to 10 general hospitals
Nam Doo-hyun
2018.05.23 11:01
Refusals of off-label drugs spiked last year
Nam Doo-hyun
2018.05.17 15:16
How China’s scrapping of tariffs will affect Korea’s drug exports?
Nam Doo-hyun
2018.05.16 11:53
Merck’s Erbitux extends RSA status
Nam Doo-hyun
2018.05.15 14:26
Biotech shares weaken on KONEX, too
Nam Doo-hyun
2018.05.15 13:50
‘Breast cancer drug Faslodex needs insurance coverage’
Nam Doo-hyun
2018.05.11 11:23
Samsung BioLogics shares recover despite window dressing controversy
Nam Doo-hyun
2018.05.10 10:57
Va-Q-Tec to up investment in Korean biopharmaceuticals
Nam Doo-hyun
2018.05.09 11:28
Pharma, biotech shares tank amid Samsung BioLogics debacle
Nam Doo-hyun
2018.05.08 11:19
How much cheaper will Keytruda be as first-line treatment?
Nam Doo-hyun
2018.05.03 14:32
Will US oncology conference boost Korean biotech shares?
Nam Doo-hyun
2018.04.27 16:28
처음
이전
이전
이전
11
12
13
14
15
16
17
18
19
20
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기